Computerized Brief Intervention vs. Delayed Computerized Brief Intervention

Overview

The purpose of the study is to determine whether a computerized brief intervention for moderate risk drug use among adult primary care patients is more effective than providing such patients with a substance abuse assessment alone.

Study Type

  • Study Type: Interventional
  • Study Design
    • Allocation: Randomized
    • Intervention Model: Parallel Assignment
    • Primary Purpose: Prevention
    • Masking: None (Open Label)
  • Study Primary Completion Date: September 2014

Detailed Description

The study will enroll 80 adult primary care patients who have moderate risk drug use. Eligible participants (N = 80) will be randomly assigned to immediately receive a computerized brief intervention focused on drug use or to receive the same computerized brief intervention at 3-month follow-up. All participants will be assessed at three time points: baseline, and at 3 and 6 month follow-ups.

Interventions

  • Behavioral: Computerized Brief Intervention
    • No additional information needed.

Arms, Groups and Cohorts

  • Experimental: Computerized Brief Intervention
    • Computerized Brief Intervention is delivered using a talking, animated cartoon-like parrot that provides patient feedback, empathic reflection, and personalization regarding their drug use.
  • Other: Delayed Computerized Brief Intervention
    • Participants receive only a substance abuse assessment at baseline. At three-month follow-up, they then receive the computerized brief intervention.

Clinical Trial Outcome Measures

Primary Measures

  • Alcohol, Smoking, and Substance Involvement Screening Tests (ASSIST) Global Continuum of Illicit Drug Risk Score
    • Time Frame: 3 month follow-up
    • The ASSIST Global Continuum of Illicit Drug Risk Score ranges from 0 to 308, with higher scores indicating greater risk.

Secondary Measures

  • Alcohol, Smoking, and Substance Involvement Screening Tests (ASSIST) Global Continuum of Illicit Drug Risk Score
    • Time Frame: 6-month follow-up
    • The ASSIST Global Continuum of Illicit Drug Risk Score ranges from 0 to 308, with higher scores indicating greater risk.

Participating in This Clinical Trial

Inclusion Criteria

  • (1) minimum 18 years of age – (2) primary care or dental patients at the participating clinics – (3) score between 4 and 26 (moderate-risk) for illicit drug and/or nonmedical use of prescription drugs on any of the single item drug use risk scores of the ASSIST. Exclusion Criteria:

  • (1) score in the high-risk range on the ASSIST for any drug (except tobacco) or alcohol use (i.e., ASSIST score > 26) – (2) no reported drug use within the past 3 months – (3) drug abuse treatment within the past 12 months – (4) a BI at the clinic with the behavioral health counselor within the past month – (5) prior enrollment in the parent study; – (6) plans to move out of New Mexico in the next 6 months

Gender Eligibility: All

Minimum Age: 18 Years

Maximum Age: N/A

Are Healthy Volunteers Accepted: Accepts Healthy Volunteers

Investigator Details

  • Lead Sponsor
    • Friends Research Institute, Inc.
  • Provider of Information About this Clinical Study
    • Sponsor
  • Overall Official(s)
    • Robert P Schwartz, M.D., Principal Investigator, Friends Research Institute, Inc.

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.